Company Valuation: DermTech

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023
Market Cap 1 148.4 635.7 469.5 53.48 59.93
Change - 328.47% -26.14% -88.61% 12.05%
Enterprise Value (EV) 1 133 572.2 252.1 -16.86 58.46
Change - 330.3% -55.95% -106.69% 446.77%
P/E -4.41x -15.6x -5.83x -0.46x -0.57x
PBR 12.3x 10.6x 2.05x 0.41x 1.06x
PEG -0.1x 0.6x -0.2x -0x 0x
Capitalization / Revenue 44.1x 108x 39.7x 3.68x 3.92x
EV / Revenue 39.5x 97.2x 21.3x -1.16x 3.82x
EV / EBITDA -7.59x -16.9x -3.3x 0.14x -0.61x
EV / EBIT -7.55x -16.7x -3.26x 0.14x -0.6x
EV / FCF -12.8x -30.9x -7.28x 0.32x -1.57x
FCF Yield -7.81% -3.24% -13.7% 314% -63.8%
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 -2.811 -2.076 -2.712 -3.884 -3.091
Distribution rate - - - - -
Net sales 1 3.364 5.885 11.84 14.52 15.3
EBITDA 1 -17.52 -33.79 -76.4 -116.5 -96.22
EBIT 1 -17.6 -34.28 -77.4 -118.2 -98.04
Net income 1 -19.69 -35.25 -78.34 -116.7 -100.9
Net Debt 1 -15.37 -63.44 -217.5 -70.34 -1.47
Reference price 2 12.400000 32.440000 15.800000 1.770000 1.750000
Nbr of stocks (in thousands) 11,964 19,595 29,717 30,215 34,243
Announcement Date 3/11/20 3/5/21 3/10/22 3/2/23 2/29/24
1USD in Million2USD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 35
41.08x6.96x33.59x - 595M
Average 41.08x 6.96x 33.59x 297.47M
Weighted average by Cap. 41.08x 6.96x 33.59x

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA